Kolon TissueGene, Inc.
A clinical-stage biopharma developing cell and gene therapies for orthopedic diseases.
950160 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840120008
- LEI:
- Country:
- United States of America
- Address:
- 9713 Key West Ave Suite 300, Rockville
- Website:
- https://www.tissuegene.com/
- Sector:
- Manufacturing
Description
Kolon TissueGene, Inc. is a clinical-stage biopharmaceutical company specializing in the development of advanced cell and gene therapies for orthopedic diseases and degenerative disorders. The company's lead product candidate, TG-C, is a first-in-class, allogeneic cell and gene therapy designed to treat knee osteoarthritis. The therapy aims to reduce pain, improve joint function, and slow the progression of the disease. TG-C is currently in late-stage clinical development, undergoing Phase 3 trials.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-02 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 39.4 KB | ||
| 2021-11-15 00:00 |
분기보고서 (2021.09)
|
Korean | 1.0 MB | ||
| 2021-08-31 00:00 |
기타시장안내(기업심사위원회 심의·의결 결과 및 개선기간 부여 안내)
|
Korean | 3.9 KB | ||
| 2021-08-31 00:00 |
주권매매거래정지기간변경(개선기간 부여)
|
Korean | 5.1 KB | ||
| 2021-08-17 00:00 |
반기보고서 (2021.06)
|
Korean | 1.1 MB | ||
| 2021-08-03 00:00 |
기타시장안내(개선계획서 제출)
|
Korean | 3.8 KB | ||
| 2021-07-13 00:00 |
기타시장안내(상장적격성 실질심사 대상 결정)
|
Korean | 5.2 KB | ||
| 2021-07-13 00:00 |
주권매매거래정지기간변경(상장적격성 실질심사 대상 결정)
|
Korean | 5.1 KB | ||
| 2021-06-25 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.2 KB | ||
| 2021-06-22 00:00 |
기타시장안내(실질심사 대상여부 결정을 위한 조사기간 연장 안내)
|
Korean | 4.1 KB | ||
| 2021-06-01 00:00 |
기타시장안내(감사의견 관련 형식적 상장폐지 사유해소 및 매매거래정지 지속 안내)
|
Korean | 6.3 KB | ||
| 2021-06-01 00:00 |
주권매매거래정지기간변경(형식적 상장폐지 사유 해소)
|
Korean | 5.2 KB | ||
| 2021-05-17 00:00 |
분기보고서 (2021.03)
|
Korean | 1.0 MB | ||
| 2021-05-10 00:00 |
기타시장안내(개선기간 종료에 따른 상장폐지 여부 결정 안내)
|
Korean | 3.3 KB | ||
| 2021-03-31 00:00 |
정기주주총회결과
|
Korean | 20.7 KB |
Automate Your Workflow. Get a real-time feed of all Kolon TissueGene, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kolon TissueGene, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kolon TissueGene, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
